Millions of peoples’ access to affordable medicines at risk if India-EFTA trade deal finalised as is: MSF
Express Pharma
FEBRUARY 14, 2024
Explaining the situation, Dr Farhat Mantoo, Executive Director, MSF South Asia informed that MSF has appealed to the Indian government through a letter to the Prime Minister to continue rightfully rejecting the inclusion of intellectual property provisions in the EFTA negotiations that are harmful for access to affordable medicines from India.
95 
Let's personalize your content